Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Folic Acid
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Recipient : McLean Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
McLean and Genomind Prospective Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 14, 2017
Lead Product(s) : Folic Acid
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Recipient : McLean Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : Medpace, Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
December 17, 2015
Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : Medpace, Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Recipient : Northwell Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 01, 2015
Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Recipient : Northwell Health
Deal Size : Inapplicable
Deal Type : Inapplicable